High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.
about
Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city.Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.Use of multiple data sources and individual case investigation to refine surveillance-based estimates of the HIV care continuum.Chronic HIV disease and activation of the coagulation systemTiming of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.Engagement in outpatient care for persons living with HIV in the United StatesImpact of age on retention in care and viral suppressionEstimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in ItalyComparison of HIV outcomes for patients linked at hospital versus community-based clinicsRetention in care within 1 year of initial HIV care visit in a multisite US cohort: who's in and who's out?Persistent HIV Viremia: Description of a Cohort of HIV Infected Individuals with ART Failure in Puerto Rico.Continuum of Care Among People Living with Perinatally Acquired HIV Infection in New York City, 2014.Antiretroviral Refill Adherence Correlates with, But Poorly Predicts Retention in HIV Care.An expanded behavioral paradigm for prevention and treatment of HIV-1 infection.Engagement with Care, Substance Use, and Adherence to Therapy in HIV/AIDS.HIV patient retention: the implementation of a North Carolina clinic-based protocol.High rates of retention and viral suppression in the US HIV safety net system: HIV care continuum in the Ryan White HIV/AIDS Program, 2011.Caring for youth living with HIV across the continuum: turning gaps into opportunities.Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.The HIV Care Cascade Among Individuals Under Community Supervision in Baltimore, Maryland.Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States.Single Viral Load Measurements Overestimate Stable Viral Suppression Among HIV Patients in Care: Clinical and Public Health Implications.Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.Barriers and Facilitators to Retaining and Reengaging HIV Clients in Care: A Case Study of North Carolina.Lost to Care and Back Again: Patient and Navigator Perspectives on HIV Care Re-engagement.Migration distorts surveillance estimates of engagement in care: results of public health investigations of persons who appear to be out of HIV care.Changes in Specific Substance Involvement Scores among SBIRT recipients in an HIV primary care setting.DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY.Do Persons Living with HIV Continue to Fill Prescriptions for Antiretroviral Drugs during a Gap in Care? Analysis of a Large Commercial Claims Database.HIV treatment outcomes in Europe and North America: what can we learn from the differences?Quarter Century of Anti-HIV CAR T Cells.Is substance use associated with HIV cascade outcomes in Latin America?
P2860
Q30840171-07D60B4B-DEF3-4262-BE5E-3B200C688A1EQ31097026-2C4CAD4F-AA15-47E2-9F8A-7462CEE1A7FAQ34338959-07C9D324-DD6D-43C8-9C30-0BEA38AA4910Q34342368-68C48F88-D30F-480E-B270-9F9C07697601Q34606589-A9315DFD-4828-45B3-BCE6-A93726FCC23CQ35033474-CAA429FC-E9A1-46CF-923C-1C7D9D627396Q35036548-1C9EE10A-C368-4D60-A11C-351306D34DBDQ35102343-A2D9C823-10D6-4560-A4AC-792C32BCE4B8Q35142504-CCEF58C7-898F-43D8-A24D-6D60DEB78C05Q35156672-8469A591-91F0-464A-8CB4-226C20756148Q36311761-1B17909C-A83E-46F4-946D-E7FE4CF4168EQ36512999-53873A4D-3950-4705-995A-FF4B03EA691DQ37075722-8FC74E77-04FC-4CF4-8F18-1BDF3361B681Q37344631-D48584BA-11A2-4FBC-8833-9DD824A40122Q37618975-71C8874A-4679-445B-A39A-660450022DAAQ37717791-F4A87750-0001-4501-A706-0914EAFB04F1Q38377611-151DDD8B-DAC7-4625-8EFE-AF3311F2701AQ38423623-A721DB4D-7344-4971-80C0-D394717E6E96Q39171219-54D05B8E-CB37-4F9F-8B9D-10042E2415F9Q39293352-1B9A85ED-1E17-4293-85C8-10DAF6D1AB2AQ39643842-BD07F9B9-6623-4618-986C-7BDFE8DA904DQ40119830-8C94D0A7-29FF-43E0-8F97-A3966552698DQ40160975-278630F9-CEDF-4395-A3E5-93CFAAA53417Q40703216-E0FC3CAD-3F3D-45C9-8241-2BA06141C703Q40785784-3F439E59-BB8C-4F6B-B845-E7CCA8DDEA29Q40910180-03BE617E-BF69-4AA2-9819-E9490177F5EDQ41924996-8232A792-129F-40A9-AFD7-5D20A09C0219Q42249872-A1086A7C-2298-486B-8EBF-41B74B560FBEQ47127356-C95F0D65-9BCD-4E8F-84BD-04BAE6296E9EQ47178726-97E0CC82-DAFA-4F21-8A9B-9532C805BF97Q50129820-F43818EF-6921-4B98-9FA6-1843CEF2CFFCQ51846375-2211A0A8-1641-4B35-8691-03CF2C31618EQ52676237-2E50C51A-4731-4C00-97FF-C9625D49FE5BQ54983898-04F1F635-0738-451A-8265-B77C6C98C879
P2860
High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
High levels of antiretroviral ...... re in the United States, 2010.
@en
type
label
High levels of antiretroviral ...... re in the United States, 2010.
@en
prefLabel
High levels of antiretroviral ...... re in the United States, 2010.
@en
P2093
P2860
P1476
High levels of antiretroviral ...... re in the United States, 2010.
@en
P2093
Heidi M Crane
Jeffrey N Martin
Julia C Dombrowski
Mari M Kitahata
Matthew R Golden
Michael J Mugavero
Richard D Moore
Stephen E Van Rompaey
Stephen L Boswell
W Christopher Mathews
P2860
P304
P356
10.1097/QAI.0B013E3182945BC7
P407
P577
2013-07-01T00:00:00Z